DSM-Firmenich stock trades at EUR 99.67, volume 74.6 percent below average

Published on 10/09/2026 at 16:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DSM-Firmenich stock has a P/E of 20.71 on October 9, 2026. EUR 99.67 stands above EUR 98.44, and market value is EUR 24.6 billion.

Key points in brief

DSM-Firmenich stock traded at EUR 99.67 at Lang & Schwarz on October 9, 2026, up 1.25 percent versus the EUR 98.44 prior close.
Trading volume was 178,008 shares, 74.64 percent below the 701,669-share average as of October 9, 2026.
Market capitalization stood at EUR 24.6 billion, with a P/E ratio of 20.71 and a 52-week range of EUR 55.22 to EUR 100.75.
An extraordinary shareholder meeting is scheduled for October 19, 2026.

Makroaufnahme goldener Aromastoff-Öltropfen mit Vitaminkristallen auf Glas — dsm-firmenich AG (ISIN CH1216478797) stellt Aromastoffe her, als goldene Öltropfen in extremer Makroaufnahme gezeigt, Illustration mit AI erstellt.

DSM-Firmenich stock (ISIN CH1216478797) was trading at EUR 99.67 at Lang & Schwarz on October 9, 2026 at 4:30 p.m. CEST, plus 1.25 percent versus the EUR 98.44 prior close. The price sits EUR 1.08 below the 52-week high of EUR 100.75, keeping the stock near the top of its annual range.

Trading volume stays below average

Trading volume reached 178,008 shares as of 4:14 p.m. CEST on October 9, 2026, compared with an average volume of 701,669 shares. That equals 74.64 percent below the average and gives the session a quieter turnover profile despite the positive price move.

The Lang & Schwarz bid was EUR 99.66 and the ask was EUR 99.68 at 4:30 p.m. CEST. The narrow EUR 0.02 spread places the latest quote close to the available market prices for the session.

Annual range leaves limited headroom

The 52-week range ran from EUR 55.22 to EUR 100.75 as of October 9, 2026. At EUR 99.67, the stock was 1.07 percent below the high, while its distance from the low was 80.49 percent.

The company reported its completed EUR 540 million share repurchase program on October 1, 2026, according to FinanzNachrichten. The release said 6,488,446 shares were intended for cancellation by the end of the first quarter of 2027, reducing issued shares by 2.6 percent from 253,626,947 to 247,138,501.

Valuation against specialty chemicals peers

DSM-Firmenich had a market capitalization of EUR 24.6 billion and a P/E ratio of 20.71 as of October 9, 2026. Its trailing dividend yield was 0.03 percent, while the finance data showed the Euronext Amsterdam quote at EUR 99.82 at 4:14 p.m. CEST.

Comparison with peers

DSM-Firmenich: plus 1.25 percent, P/E 20.71, market capitalization EUR 24.6 billion

Givaudan (SIX, CHF): plus 1.23 percent, P/E 25.63, market capitalization CHF 31.9 billion

Symrise (Xetra, EUR): plus 1.19 percent, P/E 34.57, market capitalization EUR 12.6 billion

Shareholder meeting set for October 19

An extraordinary shareholder meeting is scheduled for October 19, 2026, according to VZ VermögensZentrum. The date gives the next clearly identified corporate calendar point after the October 9 trading session.

DSM-Firmenich price snapshot

At Lang & Schwarz, DSM-Firmenich was trading at EUR 99.67 on October 9, 2026 at 4:30 p.m. CEST, plus 1.25 percent versus the EUR 98.44 prior close. The further course of trading is shown by the continuously updated real-time quote of DSM-Firmenich stock.